Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract

Virchows Archiv

Volumn 441, Issue 6, 2002, Pages 559-563

  Nakanishi, Kuniaki ^a   Tominaga, Susumu ^a   Hiroi, Sadayuki ^a   Kawai, Toshiaki ^a   Aida, Shinsuke ^a   Kasamatsu, Hiroyasu ^a   Aurues, Takashi ^a   Hayashi, Takuya ^a   Ikeda, Tomosumi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Survivin; Transitional cell carcinoma; Upper urinary tract

Indexed keywords

CYCLINE; PROTEIN BCL 2; PROTEIN P53; SURVIVIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; TUMOR CELL; URINARY TRACT CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0036456482     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-002-0712-z     Document Type: Article

References (31)

1. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC (1998) Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152:43-49
2. Altieri DC, Marchisio C (1999) Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab Invest 79:1327-1333
3. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921
4. Atug F, Turkeri L, Ozyurek M, Akdas A (1998) Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder. Int Urol Nephrol 30:455-461
5. Chiodino C, Cesinaro AM, Ottani D, Fantini F, Giannetti A, Trentini GP, Pincelli C (1999) Communication: Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol 113:415-418
6. Clem RJ, Miller LK (1994) Control of programmed cell death by the baculovirus genes p35 and iap. Mol Cell Biol 14:5212-222
7. Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300-304
8. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC (1999) Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 19:5242-5251
9. Fontanim G, Vignati S, Bigini D, Mussi A, Lucchi M, Angeletti CA, Basolo F, Bevilacqua G (1995) Bcl-2 protein: A prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer 71:1003-1007
10. Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, Shroyer KR (2001) Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 32:119-125
11. Ginsberg D, Mechta F, Yaniv M, Oren M (1991) Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci U S A 88:9979-9983
12. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095-2097
13. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J, Fujii Y (2001) Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy. Int J Cancer 95:92-95
14. Kawasaki H, Altieri DC, Lu C-D, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071-5074
15. Konno R, Yamakawa H, Utsunomiya H, Ito K, Sato S, Yajima A (2000) Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Repro 6:529-534
16. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614-620
17. Lu C-D, Altieri DC, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808-1812
18. Lu QL, Abel P, Foster CS, Lalani FN (1996) bcl-2: Role in epithelial differentiation and oncogenesis. Hum Pathol 27:102-110
19. Monzó M, Rosell R, Felip E, Astudillo J, Sánchez JJ, Maestre J, Martín C, Font A, Barnadas A, Abad A (1999) A novel antiapoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancer. J Clin Oncol 17:2100-2104
20. Murphy WM, Beckwith JB, Farrow GM (1994) Tumors of the Kidney, Bladder, and Related Urinary Structures. Atlas of Tumor Pathology, Third Series, fasc. 11. Armed Forces Institute of Pathology, Washington DC, pp 202-219
21. Nakanishi K, Kawai T, Torikata C (1996) Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract. Hum Pathol 27:1336-1340
22. Nakanishi K, Tominaga S, Kawai T, Torikata C, Aurues T, Ikeda T (1998) Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract. Virchows Arch 432:445-450
23. Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H, Dimopoulos MA (1998) The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum Pathol 29:146-154
24. Pezzella F, Turley M, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY (1993)bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694
25. Sarela AI, Macadam RCA, Farmery SM, Markham AF, Guillou PJ (2000) Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46:645-650
26. SAS Institute (1991) SAS Technical Report P-217, SAS/STAT Software, The PHREG Procedure, Version 6. SAS Institute Inc. Cary, NC, pp 63
27. Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC (2001) Urine detection of survivin and diagnosis of bladder cancer. JAMA 285:324-328
28. Swana HS, Grossmann D, Anthony JN, Weiss RM, Altieri DC (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. New Engl J Med 341:452-453
29. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6:127-134
30. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462
31. UICC (International Union Against Cancer), Renal pelvis and ureter (1992) In: Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours, 3rd Edn. Springer, Berlin Heidelberg New York, pp 270-273